β1 and β3 integrins in breast, prostate and pancreatic cancer: A novel implication.

about

Role of extracellular matrix in breast cancer development: a brief update.HDAC Inhibition Counteracts Metastatic Re-Activation of Prostate Cancer Cells Induced by Chronic mTOR Suppression

P2860

Q55495934-EA391BAC-A3EC-4196-A285-AA7EE5AD3228 Q58773654-1C7CD524-3B38-4062-B709-29CFF3601845

P2860

β1 and β3 integrins in breast, prostate and pancreatic cancer: A novel implication.

Item

http://www.wikidata.org/entity/Q52647715

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

β1 and β3 integrins in breast, prostate and pancreatic cancer: A novel implication.

@en

β1 and β3 integrins in breast, prostate and pancreatic cancer: A novel implication.

@nl

type

Item

label

β1 and β3 integrins in breast, prostate and pancreatic cancer: A novel implication.

@en

β1 and β3 integrins in breast, prostate and pancreatic cancer: A novel implication.

@nl

prefLabel

β1 and β3 integrins in breast, prostate and pancreatic cancer: A novel implication.

@en

β1 and β3 integrins in breast, prostate and pancreatic cancer: A novel implication.

@nl

P1476

β1 and β3 integrins in breast, prostate and pancreatic cancer: A novel implication.

@en

P2093

Boju Pan

http://www.w3.org/2001/XMLSchema#string

Junchao Guo

http://www.w3.org/2001/XMLSchema#string

Quan Liao

http://www.w3.org/2001/XMLSchema#string

Yupei Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Integrins in cancer: biological implications and therapeutic opportunities

The cancer glycocalyx mechanically primes integrin-mediated growth and survival

An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition.

Talins and kindlins: partners in integrin-mediated adhesion.

Flipping the switch: integrin switching provides metastatic competence

Talin1 phosphorylation activates β1 integrins: a novel mechanism to promote prostate cancer bone metastasis.

Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial-mesenchymal transition mediating pancreatic cancer cells invasion

Phase I and pharmacokinetic study of etaracizumab (Abegrin), a humanized monoclonal antibody against alphavbeta3 integrin receptor, in patients with advanced solid tumors.

Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme.

Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone.

P304

5412-5416

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.8076

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29556293

http://www.w3.org/2001/XMLSchema#string

P932

5844128

http://www.w3.org/2001/XMLSchema#string

β1 and β3 integrins in breast, prostate and pancreatic cancer: A novel implication.

about

P2860

P2860

β1 and β3 integrins in breast, prostate and pancreatic cancer: A novel implication.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932